Microtubule-stabilizing agents: a growing class of important anticancer drugs

被引：127
作者：
Altmann, KH [1 ]
机构：
[1] Novartis Pharma AG, Corp Res, CH-4002 Basel, Switzerland
来源：
CURRENT OPINION IN CHEMICAL BIOLOGY | 2001年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1367-5931(00)00225-8
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Microtubule-stabilizing agents continue to play an important role in anticancer drug discovery and development. New agents were again discovered in the past year, including small synthetic molecules. At least three new taxanes and two compounds of the epothilone class of natural products underwent clinical trials in 2000. Unexpected new findings about synergistic effects between different microtubule-stabilizing agents in vitro raise new prospects for combination chemotherapy.
引用
收藏
页码：424 / 431
页数：8
相关论文
共 64 条
  • [1] Epothilones and related structures - a new class of microtubule inhibitors with potent in vivo antitumor activity
    Altmann, KH
    Wartmann, M
    O'Reilly, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2000, 1470 (03): : M79 - M91
  • [2] Altmann KH, 2000, CHIMIA, V54, P612
  • [3] The potent microtubule-stabilizing agent (+)-discodermolide induces apoptosis in human breast carcinoma cells - preliminary comparisons to paclitaxel
    Balachandran, R
    ter Haar, E
    Welsh, MJ
    Grant, SG
    Day, BW
    [J]. ANTI-CANCER DRUGS, 1998, 9 (01) : 67 - 76
  • [4] Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO
  • [5] 2-5
  • [6] BOLLAG DM, 1995, CANCER RES, V55, P2325
  • [7] A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products
    Borzilleri, RM
    Zheng, XP
    Schmidt, RJ
    Johnson, JA
    Kim, SH
    DiMarco, JD
    Fairchild, CR
    Gougoutas, JZ
    Lee, FYF
    Long, BH
    Vite, GD
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (37) : 8890 - 8897
  • [8] Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel
    Chou, TC
    Zhang, XG
    Harris, CR
    Kuduk, SD
    Balog, A
    Savin, KA
    Bertino, JR
    Danishefsky, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15798 - 15802
  • [9] Desoxyepothilone B:: An efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B
    Chou, TC
    Zhang, XG
    Balog, A
    Su, DS
    Meng, DF
    Savin, K
    Bertino, JR
    Danishefsky, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) : 9642 - 9647
  • [10] Ciomei M., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P5
1234567